How is coronavirus affecting our operations? Learn more

neuroprotection

Prevention of Cell Death

A team of researchers led by Professor Giovanna Mallucci from the Medical Research Council (MRC) Toxicology Unit at the University of Leicester, who last year identified a major pathway leading to brain cell death in mice, have used an orally administered compound to block the pathway and have prevented neurodegeneration in the mice. The team…

Print this page Print this page

Michael J. Fox Foundation awards grant for Exenatide research

Following encouraging results recently published in the Journal of Clinical Investigation describing the progress of a cohort of patients treated with Exenatide for their Parkinson’s disease (PD), The Michael J. Fox Foundation for Parkinson’s Research has awarded a grant of $1.98 million to Dr. T Foltynie to pursue this avenue of research.  Exenatide is a…

Print this page

Exenatide may be disease-modifying for PD

Exenatide is a type 2 diabetes treatment that has been shown to have neuroprotective/neurorestorative properties in preclinical models of neurodegeneration. A new study by Aviles-Olmos et al published in the Journal of Clinical Investigation reports on the results of a trial to evaluate the progress of 45 patients with moderate Parkinson’s disease (PD). Single-blinded rating…

Print this page